CUR is listed on the Russell index . The good part is the exposure . The bad part is as the Russell goes so will CUR . Bad days for the market shows up as bad days for CUR . Goldman Sachs holds the shorts on new companies that are now listed on the Russell . CUR is just 1 of many in the basket . As Neuralstem progresses they will be noticed by the world and as Goldman reacts buying shares to cover the stock will go up .
What has happened to our positive news on this company? Where are we with our new office in China? What about India? What is going on in Taiwan? Germany? When will our Phase 1 for spinal injury be taken off hold? I think that a little PR on some of these items would go a long way to help inform buyers of the company's potential. Just some updates , please! get something out that causes investors to notice the company and the work being done.